Stocks · Health care · Pharmaceutical Preparations

Jazz Pharmaceuticals plc

JAZZ Clue Score41
Ireland Fiscal year ends December CIK 0001232524 Results filed 2 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Renee D Gala
3 Nov 2026
President & CEO
Sold on a plan
1,000
$225.37
$225.37K
Bruce C Cozadd
2 Nov 2026
Director
Sold on a plan
6,000
$215.84
$1.30M
Renee D Gala
6 Oct 2026
President & CEO
Sold on a plan
2,000
$236.40
$472.80K
Bruce C Cozadd
1 Oct 2026
Director
Sold on a plan
6,000
$230.33
$1.38M
Neena M Patil
10 Sep 2026
EVP & Chief Legal Officer
Sold on a plan
1,200
$240.94
$289.13K
Renee D Gala
8 Sep 2026
President & CEO
Sold on a plan
2,000
$243.03
$486.06K
Bruce C Cozadd
1 Sep 2026
Director
Sold on a plan
6,000
$250.13
$1.50M
Bruce C Cozadd
3 Aug 2026
Director
Sold on a plan
6,000
$252.98
$1.52M
Bruce C Cozadd
1 Jul 2026
Director
Sold on a plan
6,000
$240.47
$1.44M
Mark Douglas Smith
15 Jun 2026
Director
Sold on a plan
1,157
$230.55
$266.75K
Neena M Patil
10 Jun 2026
EVP & Chief Legal Officer
Sold on a plan
1,200
$231.83
$278.20K
Bruce C Cozadd
1 Jun 2026
Director
Sold on a plan
6,000
$235.12
$1.41M
Neena M Patil
28 May 2026
EVP & Chief Legal Officer
Sold on a plan
1,192
$236.97
$282.47K
Bruce C Cozadd
1 May 2026
Director
Sold on a plan
6,000
$203.33
$1.22M
Bruce C Cozadd
1 Apr 2026
Director
Sold on a plan
24
$191.74
$4.60K
Bruce C Cozadd
1 Apr 2026
Director
Sold on a plan
2,292
$190.94
$437.63K
Bruce C Cozadd
1 Apr 2026
Director
Sold on a plan
3,684
$190.22
$700.78K
Bruce C Cozadd
3 Mar 2026
Director
Sold on a plan
233
$187.84
$43.77K
Bruce C Cozadd
3 Mar 2026
Director
Sold on a plan
2,608
$186.73
$487.00K
Bruce C Cozadd
3 Mar 2026
Director
Sold on a plan
3,159
$186.09
$587.84K
Robert Iannone
17 Nov 2025
EVP, Global Head of R&D & CMO
Sold on a plan
7,159
$168.26
$1.20M

What was left out

Form 4 filings counted 86
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 21
Sales straight out of an exercise 29
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 536,121
History held since 1 Jun 2007